CONTEXT: Brief abstract of a real-world study on the association of patient reported pain and quality of life in multiple myeloma patients. The study on patients from Germany and Italy Continue Reading
CONTEXT: A significant announcement from ConcertAI as they start a 5-year collaborative research programme with the FDA’s Center for Drug Evaluation and Research (CDER). The aim of the research is Continue Reading
CONTEXT: Commercial announcement from Clarify Health, a cloud analytics company, on new applications of their anonymised patient-level insights. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: Continue Reading
CONTEXT: Presentation at the European Hematology Association (EHA) 2021 Virtual Congress of a post-approval safety study on Truxima (biosimiliar rituximab) in patients with large B-cell lymphoma. Results showed similar results Continue Reading
CONTEXT: Report from the European Hematology Association Annual Meeting on a real-world study looking at uses of axicabtagene ciloleucel (Yecarta) and tisagenleucel Kymriah). A review of 93 patients in the Continue Reading
CONTEXT: New data being presented at the European Hematology Association (EHA) 2021 Virtual Congress on the treatment of sickle cell disease with Oxbryta (voxelotor). Two real-world evidence studies support the Continue Reading
CONTEXT: When is Real-World Research done with randomised, double-blind study designs? Answer – when the patients involved are effectively an outcome measure. Despite the non-RWR headline title, this report of Continue Reading
CONTEXT: Continuing the theme of under-representation in clinical trials that develop new treatments, especially in oncology, this article reports on the discussion at the European Hematology Association (EHA) 2021 Virtual Continue Reading
CONTEXT: Further evidence of ancestry-based disparities in cancer treatment from this study, believed to be the largest of it’s type so far. The analysis of data from over 11,000 men Continue Reading
CONTEXT: Launch announcement for a patient-centric chronic pancreatitis registry, PACT-CP. The registry will be Us only and aims to assess unmet needs, therapeutic burden and the overall patient experience. IMPACT: Continue Reading
